Journal
NEUROIMMUNOMODULATION IN HEALTH AND DISEASE
Volume 1351, Issue -, Pages 52-60Publisher
BLACKWELL SCIENCE PUBL
DOI: 10.1111/nyas.12821
Keywords
multiple sclerosis; immune response; interleukin-6; leukemia inhibitory factor; oncostatin M; interleukin-11
Categories
Ask authors/readers for more resources
Multiple sclerosis (MS) is a chronic disabling autoimmune disease of the central nervous system. The interleukin (IL)-6 cytokine family plays a crucial role in regulating the immune response in MS. All members of the IL-6 family share the common signal-transducing receptor protein, glycoprotein 130. Although the intracellular signaling of these cytokines seems to be largely overlapping, they have diverse and contrasting effects on the immune response. This review focuses on the effects of the family members IL-6, leukemia inhibitory factor, oncostatin M, and IL-11 on immune cell subsets and how these effects relate to the pathogenesis of MS. Finally, we propose possible avenues to modulate these family members for future MS therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available